Enovis (ENOV) Free Cash Flow (2010 - 2026)
Enovis' (ENOV) quarterly Free Cash Flow came in at $31.1 million in Q3 2026, up 815.79% year-over-year from $3.4 million in Q3 2025, and up 207.92% quarter-over-quarter from -$28.9 million in Q2 2026.
Analysis
Enovis (ENOV) Free Cash Flow (2010 - 2026) Analysis & Trends
Enovis (ENOV) has reported Free Cash Flow for 17 consecutive years, with $31.1 million the latest figure, recorded in Q3 2026.
- On a quarterly basis, Free Cash Flow rose 815.79% year-over-year to $31.1 million in Q3 2026; TTM through Jul 2026 was $63.7 million, a 1710.8% increase from a year earlier, with the FY2025 full-year figure at $19.9 million, up 129.63% from the prior year.
- Free Cash Flow was $31.1 million for Q3 2026 at Enovis, up from -$28.9 million in the prior quarter.
- Over five years, Free Cash Flow peaked at $40.5 million in Q4 2023 and troughed at -$73.1 million in Q1 2024.
- A 5-year average of -$10.8 million and a median of -$5.1 million in 2022 frame the typical range for Free Cash Flow.
- Across the five-year window, Free Cash Flow slumped 263.5% in 2024 and surged 1128.25% in 2025, its largest moves.
- Over 5 years, Free Cash Flow stood at -$72.7 million in 2022, then surged by 155.64% to $40.5 million in 2023, then slipped by 13.18% to $35.1 million in 2024, then dropped by 8.11% to $32.3 million in 2025, then retreated by 3.57% to $31.1 million in 2026.
- The last three Free Cash Flow figures came in at $31.1 million (Q3 2026), -$28.9 million (Q2 2026), and $32.3 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.19 Bn | 175.58 Bn | 7.27 Bn | 1.99 Bn |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn | 948.40 Mn |
| 3 | Medtronic | 117.13 Bn | 108.31 Bn | 6.34 Bn | 1.29 Bn |
| 4 | Stryker | 104.67 Bn | 101.20 Bn | 4.50 Bn | 1.06 Bn |
| 5 | Boston Scientific | 64.48 Bn | 63.94 Bn | 3.85 Bn | 1.28 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 585.00 Mn |
| 7 | Alcon | 33.06 Bn | 31.61 Bn | 1.68 Bn | 606.00 Mn |
| 8 | Dexcom | 32.37 Bn | 30.43 Bn | 830.00 Mn | 184.50 Mn |
| 9 | Steris | 20.76 Bn | 20.28 Bn | 684.20 Mn | 279.60 Mn |
| 10 | Enovis | 1.07 Bn | 1.06 Bn | 359.25 Mn | 31.14 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 31.14 Mn |
| Apr 3, 2026 | -28.85 Mn |
| Dec 31, 2025 | 32.29 Mn |
| Oct 3, 2025 | 29.09 Mn |
| Jul 4, 2025 | 3.40 Mn |
| Apr 4, 2025 | -44.86 Mn |
| Dec 31, 2024 | 35.14 Mn |
| Sep 27, 2024 | 2.37 Mn |
| Jun 28, 2024 | -31.63 Mn |
| Mar 29, 2024 | -73.08 Mn |
| Dec 31, 2023 | 40.47 Mn |
| Sep 29, 2023 | 3.98 Mn |
| Jun 30, 2023 | -8.70 Mn |
| Mar 31, 2023 | -22.99 Mn |
| Dec 31, 2022 | -72.74 Mn |
| Sep 30, 2022 | -1.46 Mn |
| Jul 1, 2022 | -48.60 Mn |
| Apr 1, 2022 | -38.51 Mn |
| Dec 31, 2021 | 65.57 Mn |
| Oct 1, 2021 | 68.18 Mn |